HOME >> BIOLOGY >> NEWS
European Science Foundation's Forward Look reaches out beyond the endless frontiers

Forward Look exercise on Nanomedicine. The Forward Look exercise has been considered as an important source of inspiration for the European Commissions Strategic Research Agenda of the European Technology Platform on Nanomedicine and has left impactful marks on the ECs Seventh Framework Programme calls.

Three of the more recent Forward Looks topics are focused on developments and challenges in the natural sciences. These Forward Looks have all included some typical foresight methods, such as scenario building, road mapping, interactive workshops or key word analysis. In the Forward Look Nanomedicine, a SWOT analysis (evaluating the Strengths, Weaknesses, Opportunities and Threats for Europe in an international context) was used to structure the current state of affairs and future developments.

The Forward Looks final reports, as the one on Nanosciences and the Long-term Evolution of Information Technology (NSIT), typically develop science policy recommendations and strategies at the European level. These reports are aware that the Forward Look is part of a broader policy-making process needing coherent and comprehensive recommendations, and their conclusions take into account the opportunities and weaknesses of the current structures and dynamics of the European Research Area. Moreover, the priorities suggested by these reports are more explicit in the sense that they are not just seen as new emerging themes but as frameworks to coordinate the dynamics of these specific fields at an international level.

In the Forward Look Systems Biology a plea is made to create a European road map to develop the Grand Challenge on Systems Biology for Europe.

The current invitation for significant Forward Look topics, pronounced by the ESF in July 2007, is expected to initiate once more foresight exercises at the highest scientific level with European relevance.

Impacts of former and present Forward Looks

'"/>

Contact: Christoph Ettl
cettl@esf.org
33-388-767-154
European Science Foundation
8-Aug-2007


Page: 1 2 3 4 5 6

Related biology news :

1. The UAB heads a European research project on proteases and pathological processes
2. Journalists can register now for ECCO 14 -- the European Cancer Conference
3. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
4. Early Europeans unable to stomach milk
5. European launch of International Polar Year 2007-2008
6. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
7. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
8. European launch of International Polar Year 2007-2008
9. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
10. Putting a face on the earliest modern Europeans
11. European Union outpaces United States on chemical safety

Post Your Comments:
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/13/2015)... -- higi, a leading cloud-based consumer engagement platform that provides ... their communities around health and wellness, announced today the ... ... convenient vehicle to receive validated health information from consumers. ... API will allow higi,s trusted partners, on a user ...
(Date:4/9/2015)... 9, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the third ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
(Date:5/29/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... that results of a large, European single-center experience ... hepatic metastases with the Delcath Hepatic CHEMOSAT ® ... abstract at the American Society of Clinical Oncology ...
(Date:5/29/2015)... 29, 2015  Caris Life Sciences® today announced ... which researchers utilized Caris Molecular Intelligence®, the company,s ... therapeutic targets in patients with colorectal and pancreatic ... cell death protein 1 (PD-1) and its ligand, ... the 2015 American Society of Clinical Oncology Annual ...
(Date:5/29/2015)... , May 28, 2015 Research ... addition of Jain PharmaBiotech,s new report "Cytogenetics ... offering. This report deals with cytogenetics ... use mainly to describe the chromosome structure and ... of molecular biology, it is also referred to ...
(Date:5/29/2015)... MILWAUKEE, WISCONSIN (PRWEB) May 29, 2015 ... oncolytic virus talimogene laherparepvec and its ability to reduce ... the treatment have been published in the Journal of ... 436 patients with stages IIIB, IIIC and IV melanoma, ... goal of the study was to evaluate the safety ...
Breaking Biology Technology:Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2
Cached News: